Primavera Capital Group
Primavera Capital Group is a china-based investment firm, focusing on private equity and special situations opportunities.
Business Model:
Revenue: $185.4M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Primavera Capital Group Information
Geographic Data
Address: No.1 Jian Guo Men Wai Avenue
City: Beijing
State: beijing municipality
Zip: 100004
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$5B
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Primavera Capital Group is a China-based global investment firm. With offices located in Beijing and Hong Kong, Primavera manages both RMB and USD funds for leading institutions, corporations, and families in China and around the world. Primavera Capital Group was founded by Dr. Fred Hu, a renowned economist and successful investor, and a former partner and Chairman of Greater China at Goldman Sachs Group. The firm currently has 30+ investment professionals with an outstanding track record. The team combines global capital market experience, deep industry knowledge, and a unique network of relationships with policy-makers and regulators as well as leading CEOs and entrepreneurs in the region and globally. Primavera Capital Group puts great emphasis on rigorous fundamental research. The firm undertakes sophisticated analysis on economies, industries and companies to generate investment ideas, identify attractive opportunities, and guide its investment decisions. Primavera Capital Group employs a flexible investment strategy of growth capital, buy-out and control, and special situations - restructuring, distressed, and turn-arounds, etc.
Contact Phone:
Contact Email:
Primavera Capital Group went public on 1/22/2021 on the NYSE
Listed Exchange:
NYSE
IPO Date:
1/22/2021
Ticker Symbol:
PV.U
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2021 | Beisen | Series F | 0 |
| 11/2018 | Alibaba Bendi Shenghuo Fuwu Gongsi | Funding Round | 4B |
| 12/2021 | Avistone Pharmaceuticals | Private Equity Round | 0 |
| 7/2017 | Moviebook | Series C | 73.8M |
| 1/2017 | Koubei | Private Equity Round | 1.1B |
| 10/2018 | ByteDance | Equity | 3B |
| 6/2020 | Xingsheng Youxuan | Corporate Round | - |
| 2/2022 | Adden Energy | Seed Round | 5.2M |
| 7/2021 | OptoMedic | Series D | - |
| 9/2021 | Accession Therapeutics Limited | Seed Round | - |
| 10/2019 | Danke Apartment | Series D | 190M |
| 3/2022 | Hex Trust | Series B | 0 |
| 6/2022 | Project Twelve | Seed Round | 8M |
| 4/2016 | Ant Group | Series B | 0 |
| 7/2017 | Dashu Finance | Series C | 118M |
| 3/2016 | Cainiao Logistics | Series A | 1.5B |
| 5/2021 | Analytical Biosciences | Series A | - |
| 8/2022 | Enflame | Series C | - |
| 4/2019 | Onion Math | Series D | 44.7M |
| 2/2019 | Danke Apartment | Series C | 500M |
| 9/2012 | Alibaba Group | Private Equity Round | 0 |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 10/2021 | Ruigu | Series D | 250M |
| 12/2021 | Xbiome | Series B | 0 |
| 1/2021 | Enflame | Series C | 278.8M |
| 1/2021 | 4Paradigm | Series D | 0 |
| 11/2022 | Subtle Medical | Series B | 25M |
| 5/2021 | Jenscare Biotech | Venture Round | - |
| 5/2022 | Trash Warrior | Series A | 0 |
| 5/2018 | Souche | Series F | 578M |
| 11/2017 | WorldStrides | Private Equity Round | - |
| 12/2021 | SyMap Medical | Series E | 100M |
| 1/2020 | Zap Surgical Systems | Private Equity Round | 0 |
| 8/2019 | Ubox | Corporate Round | 225.5M |
| 2/2022 | Hong Kong Asia Heart Centre | Series D | 0 |
| 11/2019 | LBX Pharmacy | Post-IPO Secondary | 557M |
| 8/2022 | Pingxin Technology | Series A | - |
| 12/2018 | Lu.com | Series C | 0 |
| 11/2017 | Souche | Series E | 335M |
| 10/2021 | GoTo Group | Private Equity Round | 0 |
| 12/2018 | Hello TransTech | Series G | 581.5M |
| 11/2020 | Deepinfar Ocean Technology | Series B | 0 |
| 8/2018 | Xpeng Motors | Series B | 584.5M |
| 1/2022 | Starfield Food &a; Science Technology | Series B | 0 |
| 5/2022 | Dimension | Seed Round | 8M |
| 11/2020 | Xbiome | Funding Round | - |
| 3/2012 | Xunlei | Series E | 50M |
| 3/2022 | Robotphoenix | Series D | 0 |
| 2/2021 | Xingsheng Youxuan | Series D | 0 |
| 8/2021 | Shukun Technology | Series D | 105.8M |
| 11/2019 | Shijiazhuang Junlebao Dairy | Funding Round | 569.1M |
| 6/2021 | Trash Warrior | Seed Round | 1.5M |
| 10/2021 | Love, Bonito | Series C | 0 |
| 7/2018 | Zuoyebang | Series D | 350M |
| 1/2023 | Blackpanda | Series A | 15M |
| 9/2016 | Yum! China | Private Equity Round | 460M |
| 10/2021 | Envision Group | Private Equity Round | 1B |
| 11/2022 | Accession Therapeutics | Series A | 0 |
| 8/2022 | Pingxin Technology | Series A | - |
| 6/2022 | Project Twelve | Seed Round | 0 |
| 5/2022 | Trash Warrior | Series A | 0 |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 3/2022 | Hex Trust | Series B | 0 |
| 3/2022 | Robotphoenix | Series D | 0 |
| 2/2022 | Hong Kong Asia Heart Centre | Series D | 0 |
| 1/2022 | Starfield Food &a; Science Technology | Series B | 0 |
| 12/2021 | Xbiome | Series B | 0 |
| 12/2021 | Avistone Pharmaceuticals | Private Equity Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
